Chief Investigator - Associate Professor Karen Barker
Trial Manager - Nicola Kenealy
Research Physiotherapist/ PI at Nuffield Orthopaedic Centre - Jon Room
The Primary objective for the CORKA trial is:
- To compare the patient reported functional outcome and quality of life of the CORKA trial rehabilitation protocol versus standard care in participants at risk of poor outcome after knee replacement.
Secondary objectives for the CORKA trial are:
- To assess the safety and serious adverse events associated with the treatment programme
- To assess the acceptability to the treatment programme for patients and therapists through both a RCT and a nested qualitative study
- To assess the cost effectiveness of the different treatment strategies
The following outcome measures will be collected at baseline, 6 months and 12 months
- Late Life Function and Disability Instrument (LLFDI)
- Oxford Knee Score
- Physical Activity Scale for the Elderly (PASE)
- Functional Co-morbidities Index
- Physical measures :– 30 sec Chair Stand test, Figure of 8 test, Single leg stance
- Participant diaries – exercise, medication, use of healthcare services, falls (time to first fall), adverse events
The Target of 620 has been reached. Recruitment and follow up for the CORKA trial has now been completed.
The trial is currently under analysis and we hope to make the results known from February 2020! Check back then for details.
Well done to all of the sites for their participation and collecting the follow up data, we had over 90% return rate which is fantastic.
CONGRATULATIONS to the Teams of Dorset Healthcare and Dorset County Hospital for recently winning an Outstanding Achievement Award at the CRN Wessex Awards Ceremony for successfully working in collaboration on the CORKA Trial.
This is a great achievement, well done.